Oncolys BioPharma
4588.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| SMBC Nikko Securities Inc. | 4.58% |
| Evo Fund | 4.31% |
| Gomi Daisuke | 3.91% |
| Morgan Stanley & Co. LLC | 1.29% |
| Morgan Stanley MUFG Securities Co., Ltd. | 0.87% |
| Morgan Stanley & Co. International plc | 0.61% |
| Sumitomo Mitsui Banking Corporation | 0.00% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 36
| Holder | Ratio | Change |
|---|---|---|
| Gomi Daisuke2026-01-16 · amended | 3.91% | new |
| Morgan Stanley & Co. International plc2026-01-08 · amended | 0.61% | -0.44pp |
| Morgan Stanley MUFG Securities Co., Ltd.2026-01-08 · amended | 0.87% | -1.61pp |
| Morgan Stanley & Co. LLC2026-01-08 · amended | 1.29% | -0.74pp |
| Morgan Stanley & Co. International plc2026-01-08 · amended | 1.05% | new |
| Morgan Stanley & Co. LLC2026-01-08 · amended | 2.03% | new |
| Morgan Stanley MUFG Securities Co., Ltd.2026-01-08 · amended | 2.48% | new |
| SMBC Nikko Securities Inc.2025-11-21 | 4.58% | -4.50pp |
| Sumitomo Mitsui Banking Corporation2025-10-27 | 0.00% | -0.75pp |
| SMBC Nikko Securities Inc.2025-10-27 | 9.08% | -0.41pp |
| Sumitomo Mitsui Banking Corporation2025-10-17 | 0.75% | +0.75pp |
| SMBC Nikko Securities Inc.2025-10-17 | 9.49% | -1.36pp |
| Sumitomo Mitsui Banking Corporation2025-10-14 | 0.00% | -0.19pp |
| SMBC Nikko Securities Inc.2025-10-14 | 10.85% | -0.92pp |
| Sumitomo Mitsui Banking Corporation2025-10-06 | 0.19% | new |
| SMBC Nikko Securities Inc.2025-10-06 | 11.77% | -1.06pp |
| SMBC Nikko Securities Inc.2025-08-22 | 12.83% | -1.01pp |
| SMBC Nikko Securities Inc.2025-08-20 | 13.84% | -0.95pp |
| SMBC Nikko Securities Inc.2025-08-12 | 14.79% | +10.36pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.